Anti-SLC2A8 ADCC Enhanced Antibody (VB1-050) is an ADCC enhanced antibody produced by our Afuco™ platform. VB1-050 is an IgG MAb generated from pooled lymphocytes of cancer patient samples, using standard hybridoma techniques. This antibody demonstrates preferential binding to a host of tumor cell lines, including breast, liver, prostate and colon, with limited normal tissue reactivity. Further research is ongoing to assess the potential clinical exploitation of VB1-050/Glut-8.
Figure 1 demonstrates antibody cell surface binding after incubation of A-375 cells at different temperatures as determined by flow cytometry.
Fluorescence labeling of A-375 cells after incubation of cell suspensions at 4°C: 4B5 (1) and VB1-050 (2). Fluorescence labeling of A-375 cells after warming antibody-bound cells to 37°C: VB1-050 for 60 min (3), for 120 min (4).
Figure 2 shows confocal microscopy assessment of VB1-050 internalization.
A-375 cells were incubated with antibody at 4°C, washed and warmed to 37°C for 60 min. Cells were fixed, permeabilized and labeled with fluorescent-labeled second antibody. Fluorescence labeling of A-375 cells after incubation of VB1-050 at 4°C for 60 min, displaying circumferential surface distribution of labeling, magnification (A). Following incubation of antibody-bound cells at 37°C for 60 min the cells show strong intracellular staining by internalized antibody, magnification (B).
Figure 3 shows the in vitro cytotoxicity of VB6-050.
MTS assay of VB6-050 with antigen-positive cells MB-435S (open circle) and antigen-negative cells Daudi (black circle). Cells seeded at 1000 cells per well, were incubated with the Fab-de-bouganin purified proteins. After 5 days incubation, the cell viability was measured and IC50 was determined.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-386CQ | Human Anti-SLC2A8 Recombinant Antibody (TAB-386CQ) | Cyt, FC, WB | Human IgG |
TAB-386CQ-S(P) | Human Anti-SLC2A8 Recombinant Antibody; scFv Fragment (TAB-386CQ-S(P)) | ELISA, WB | Human scFv |
TAB-386CQ-F(E) | Human Anti-SLC2A8 Recombinant Antibody; Fab Fragment (TAB-386CQ-F(E)) | ELISA, WB | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-3300 | Hi-Affi™ Recombinant Rabbit Anti-SLC2A8 Monoclonal Antibody (DS3300AB) | WB | IgG |
There are currently no Customer reviews or questions for AFC-551CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.